ECSP972074A - PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF RHINITIS - Google Patents

PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF RHINITIS

Info

Publication number
ECSP972074A
ECSP972074A ECSP972074A ECSP972074A EC SP972074 A ECSP972074 A EC SP972074A EC SP972074 A ECSP972074 A EC SP972074A EC SP972074 A ECSP972074 A EC SP972074A
Authority
EC
Ecuador
Prior art keywords
rhinitis
treatment
pharmaceutical compositions
pharmaceutically acceptable
acceptable salt
Prior art date
Application number
Other languages
Spanish (es)
Inventor
De Venne Herman Van
Jean-Pierre Martin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42042907&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP972074(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Priority to ECSP972074 priority Critical patent/ECSP972074A/en
Publication of ECSP972074A publication Critical patent/ECSP972074A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una composición farmacéutica que comprende una cantidad terapéuticamente eficaz de una mezcla formada esencialmente por: (i) compuesto seleccionado de pseudoefedrina, fenilpropanolamina y fenilefrina, un isómero óptico individual o una sal farmacéuticamente aceptable de la misma, y (ii) al menos un compuesto seleccionado del ácido 2-[-4(difenilmetil)-1-piperacinil]-acético o derivados amídicos, un isómero óptico individual o una sal farmacéuticamente aceptable del mismo.A pharmaceutical composition comprising a therapeutically effective amount of a mixture consisting essentially of: (i) compound selected from pseudoephedrine, phenylpropanolamine, and phenylephrine, a single optical isomer, or a pharmaceutically acceptable salt thereof, and (ii) at least one selected compound of 2 - [- 4 (diphenylmethyl) -1-piperazinyl] -acetic acid or amide derivatives, a single optical isomer or a pharmaceutically acceptable salt thereof.

ECSP972074 1997-04-08 1997-04-08 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF RHINITIS ECSP972074A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP972074 ECSP972074A (en) 1997-04-08 1997-04-08 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF RHINITIS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP972074 ECSP972074A (en) 1997-04-08 1997-04-08 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF RHINITIS

Publications (1)

Publication Number Publication Date
ECSP972074A true ECSP972074A (en) 1998-04-24

Family

ID=42042907

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP972074 ECSP972074A (en) 1997-04-08 1997-04-08 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF RHINITIS

Country Status (1)

Country Link
EC (1) ECSP972074A (en)

Similar Documents

Publication Publication Date Title
PA8426801A1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF RHINITIS.
NO20032233L (en) Synergistic compounds which include a renin inhibitor for cardiovascular diseases
EA200200571A1 (en) NEW COMPOSITION AND ITS APPLICATION
BR9915727A (en) esters derived from substituted phenyl-cyclohexyl compounds
BR9813028A (en) Prostaglandin agonists and their use to treat bone disorders
BR9707010B1 (en) compounds, pharmaceutical composition and compositions for inhibiting type iv metalloproteinase and collagenase.
BR0010555A (en) Neuraminidase Inhibitors
AR013742A1 (en) METHOD FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA WITH NON-SUBSTITUTED POLIDIALILAMINE
CO4940450A1 (en) PHARMACEUTICAL FORMULATIONS CONTAINING VORICONAZOLE
ES2196190T3 (en) INHIBITORS OF METALOPROTEINASAS MATRICIALES, WITH BIFENLICO HYDROXAMATE.
ES2081187T3 (en) NEW NAFTIL-ALQUIL-AMINAS, ITS PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
GT199900015A (en) PROCEDURE TO TREAT HEART FAILURE
PA8542901A1 (en) USE OF (Z) -2-CIANO-3-HYDROXI-BUT-2-ENOIC ACID- (4-TRIFLUOROMETILFENIL) -AMIDA TO TREAT MULTIPLE SCLEROSIS
NO304113B1 (en) Crystalline thiagabine hydrochloride monohydrate, pharmaceutical composition comprising it, and use thereof for the manufacture of a medicament
CO5070569A1 (en) COMPOUND OF AMINOAZOL OR A PHARMACEUTICALLY ACCEPTABLE SALT OF THE SAME AND MEDICINAL PRODUCT CONTAINING THEM
DK0888323T3 (en) Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
BR9507381A (en) Compound use of a compound process for the treatment of a manifest pharmaceutical composition and process for the preparation of compounds
AR018505A1 (en) ANTIHISTAMINAL PHARMACEUTICAL COMPOSITION WITH AN INHIBITOR OF P-GLYCOPROTEIN AND THE USE OF SUCH COMPOSITION FOR THE MANUFACTURE OF MEDICINES TO INCREASE THE BIODISPONIBILITY OF SUCH ANTIHISTAMINAL.
NO20014855L (en) N- (2-phenyl-4-aminobutyl) -1-naphthamides as neurokinin-1 receptor antagonists
PE45195A1 (en) DERIVATIVE OF AMINO ACID, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION THAT CONTAINS IT
BR9814495A (en) Compound, process to prepare it, use of it, pharmaceutical composition, and, process
BR9611276A (en) Compound pharmaceutical formulation process for treatment or prophylaxis of diseases or conditions of humans and use of a compound
AR002191A1 (en) ORAL PHARMACEUTICAL COMPOSITION OF PIPERIDINOALCANOL COMPOUNDS IN THE FORM OF SOLUTION, PROCEDURE FOR ITS PREPARATION
ECSP972074A (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF RHINITIS
PA8483301A1 (en) SERTRALINA ORAL CONCENTRATE